IASLC Lung Cancer News (ILCN), November 2023
ILCN | English
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
Table of Contents
  • Patient Perspective: Patients With EGFR+ NSCLC May Still Opt for Quality Over Quantity After FLAURA2
  • Transporting Real-World Evidence Between Countries—Ready to Beam Aboard?
  • Data Support IMRT as Standard of Care for Locally Advanced NSCLC
  • Media Training Improves Advocacy Reach, Increases Lung Cancer Awareness
  • IASLC Names New Chief Science Officer
  • Comparing Thoracic Radiotherapy Regimens for Limited Stage Small Cell Lung Cancer
  • Risk Prediction Model Demonstrates Superior Performance vs. NELSON Criteria for Identifying Individuals for Screening
  • New Data Support Continued Use of IASLC Staging Model for Mesothelioma
  • Hot Topic Meeting to Explore Resistance to IO in NSCLC
  • In Brief for November 8, 2023
IASLC Lung Cancer News (ILCN) is the offical news source of the only global association dedicated to the multidisciplinary study of lung cancer, published bimonthly by the International Association for the Study of Lung Cancer (IASLC). 

Click here to link to Submission Guidelines.
Powered By